To investigate homocysteine levels and their relationship with serum folate and vitamin B 12 concentrations with weight loss after the Lap-Band 1 form of gastric restrictive surgery, with the view to minimizing risk. METHODS: We measured levels of fasting plasma homocysteine (tHcy), folate (serum and RBC) and vitamin B 12 in two groups. The study group was 293 consecutive patients at 12 (n 192) or 24 (n 101) months review after surgery. The controls were 244 consecutive patients presenting for this surgery. RESULTS: The group losing weight had higher geometric mean tHcy levels: 10.4 (95% CI, 9.8 ± 10.8) mmolal compared with 9.2 (95% CI, 8.9 ± 9.7) in controls (P`0.001). This occurred with higher folate levels and unchanged vitamin B 12 levels. Levels of folate and B 12 together explained 35% (r 2 ) of the homocysteine variance in the weight loss group compared with only 9% (r 2 ) in controls (P`0.001). Those taking regular multivitamin supplements had lower tHcy levels: 9.6 (9.1 ± 10.0) mmolal vs 12.3 (11.4 ± 13.3) in those not taking supplements (P`0.001). A low normal plateau of tHcy levels occurred at levels of folate b15 ngal and B 12 b600 ngaml. A curvilinear relationship exists between these cofactors and tHcy levels, with the dose ± response relationship shifted to the right in the weight loss group. CONCLUSION: This study shows elevated tHcy levels with weight loss, without lower serum folate or vitamin B 12 levels. There is an altered dose ± response relationship with higher serum B 12 and folate levels required to maintain recommended tHcy levels. Patients losing weight have signi®cant health bene®ts; however, they may be at greater risk of vascular events or fetal abnormality in association with raised tHcy levels. Multivitamin supplementation is effective in lowering tHcy levels.
Introduction
Nutritional de®ciencies have been of great concern following weight loss surgery. Iron, vitamin B 12 and folate de®ciencies occur commonly after gastric bypass surgery and these can occur despite close follow-up. 1 ± 5 High homocysteine and low vitamin B 12 have been found in many patients who have had previous gastric resection surgery. 6 Homocysteine is an important sulfur-containing amino acid that is formed during the metabolism of methionine, an essential amino acid derived from dietary protein. Three micronutrients, folic acid, vitamin B 12 and vitamin B6, are enzyme cofactors in homocysteine metabolism. Folate and vitamin B 12 are essential in the remethylation of homocysteine to methionine and vitamin B 6 is required in the conversion of homocysteine to cystathionine, a rate-limiting step in the catabolism of homocysteine. 7 A raised plasma homocysteine level has been found to be an independent risk factor for atherosclerotic and thrombotic disease. 7 It is also established that folic acid supplements can prevent neural tube defects if taken in the months before pregnancy. Both these effects are related to homocysteine metabolism and appear to be a graded metabolic effect rather than simply a nutritional de®cit. 7, 8 It has been considered that gastric restrictive procedures are devoid of long-term nutritional complications with few patients shown to suffer de®ciency. 5, 9 This is understandable, as there is no gastric resection or bypass to restrict absorption. Two recent studies have found elevated homocysteine levels associated with weight loss. BorsonChazot et al found a signi®cant rise in homocysteine after gastric restrictive surgery associated with a small fall in serum folate. 10 A small study by Henning et al showed an elevated homocysteine with dieting and that multivitamin supplements containing folate, vitamin B 12 and vitamin B 6 had a preventative effect. 11 Patients presenting for bariatric surgery often have a number of cardiovascular risk factors such as hypertension, diabetes, impaired fasting glucose and dyslipidemia in addition to their obesity. 12 Most patients presenting are women, many of whom are planning future pregnancies. It is important that nutritional care post-operatively avoids risks and addresses nutritional and metabolic problems if found.
The aims of this study were to describe vitamin B 12 , folate and homocysteine levels in patients losing weight after the Lap Band form of gastric restrictive surgery and to study the relationship between these factors with the view to minimizing any risk of raised homocysteine levels.
Methods

Study subjects
The study group are patients with severe obesity treated by the Lap-Band system. This involves placement laparoscopically of an adjustable silicone band just below the esophagogastric junction. The procedure creates an early sense of satiety after eating and has been shown to be safe and effective. 13 Patients with a body mass index (BMI) greater than 35 kgam 2 , suffering signi®cant medical, physical or psychosocial disabilities and who have attempted weight reduction by other means for at least 5 y are considered for entry into the Lap-Band program. Pre-operative assessment includes measurement of hemoglobin and red cell indices, iron studies, serum vitamin B 12 , serum folate, red-cell folate and fasting plasma total homocysteine. Vitamin B 6 levels are not measured. All patients have given written informed consent to the surgical procedure, including the preoperative and post operative requirements. The hospital's ethics review board has approved the study's questionnaires and protocols for this group as part of a larger study.
All patients receive perioperative and postoperative dietary advice from dietitians as part of a multidisciplinary management team. In addition discussion of diet and dietary supplementation are routine at all follow-up reviews by surgeons and physicians. Patients are all advised to take a daily multivitamin and mineral supplement. They are not advised to have a high protein diet. The suggested supplement contains a minimum of iron (5 mg), vitamin C (30 mg), vitamin B 12 (20 mg), vitamin B 6 (20 mg), folic acid (400 mg) and other vitamins and minerals.
We have now measured homocysteine, folate, RBC folate and vitamin B 12 levels in 244 consecutive preoperative patients (controls) and in 293 consecutive patients at annual reviews 12 and 24 (mean 16.4) months after surgery (study group). There are 43 patients who have paired preoperative and 1 y level and are represented in both groups and 26 patients with 1 y and 2 y levels. Personal reporting of multivitamin supplement use in the last week assessed patient compliance.
Most clinical studies measure fasting total homocysteine of which 70 ± 80% is protein-bound. 7 Homocysteine levels in this paper refer to fasting total homocysteine. Normal levels of fasting plasma homocysteine are considered to be between 5 and 15 mmolal.
14 On the basis of epidemiological evidence of a relationship between plasma homocysteine and vascular disease the American Heart Association recommends levels less than 10 mmolal in patients at risk of premature vascular disease, as well as those with malnutrition or malabsorbtion syndromes. 14 
Biochemical measurements
For fasting total plasma homocysteine concentrations venous blood was collected into EDTA tubes kept on ice and plasma separated off within 4 h of collection. Specimens were stored at À20 C prior to batch analysis every 2 weeks. Pre-and postoperative samples were analyzed in any one batch. The reagent used is catalog no. 3D39-20 Abbott IMX Homocysteine reagent and assay performed on the Abbott IMX analyzer. Calibration was performed using B3D399 containing s-adenosyl-n-homocysteine in phosphate buffer. The inter-assay and intra-assay coef®cients for homocysteine level are 2.2% and 3%, respectively.
Serum vitamin B 12 and folate concentrations were measured using Chiron Diagnostics ACS-180 VB12 and folate (catalog no 10481 and 672215) reagents, respectively, and assay performed on a Bayer ACS-180. The inter-assay and intra-assay coef®cients for vitamin B 12 level are 5% and 6%, respectively, and for folate 5% and 10%, respectively.
Statistical analysis
Continuous numerical variables were assessed for normal distribution and when necessary a natural log transformation was performed prior to analysis. Log e (ln) transformation was necessary for variables: homocysteine, folate, RBC folate and Vitamin B 12 . After transformation these variables followed an acceptable normal distribution with kurtosis score`2 and bÀ2. The chi-squared test was used to test the signi®cance of proportions. Linear regression analysis was used to assess the relationship between ln B 12 , ln RBC folate and ln folate, and ln homocysteine levels. Scatter plots were used to visualize the relation between ln homocysteine and ln folate, and ln vitamin B 12 levels. Results of ln transformed data in the abstract, text and tables are presented as geometric means and are followed by 95% con®dence intervals for the mean. Continuous variables not transformed are followed by AE s. 
Results
There is no signi®cant difference between the control and study groups in their preoperative demographics ( Elevated homocysteine levels Ð altered dose response with folate and vitamin B 12 The fasting homocysteine concentration is signi®cantly higher in the group studied at annual 1 y or 2 y follow-up ( Table 2 ). The geometric mean homocysteine level for this study group was 10.4 mmolal compared with 9.2 mmolal in the control group (P`0.001). As homocysteine is proteinbound it is relevant that there is no difference in albumin and total protein levels between the groups at the time of homocysteine measurement. These high homocysteine levels in the study group are associated with signi®cantly higher levels of serum folate and no change in vitamin B 12 level (Table 2) . Linear regression analysis con®rms signi®-cantly higher homocysteine levels in the study group after controlling for both serum folate and vitamin B 12 levels (r 0.22, P`0.001).
Scatter plots with linear trend lines of the ln transformed data of homocysteine levels compared with folic acid and vitamin B 12 levels in the two groups are shown in Figures 1  and 2 , respectively. The linear trend lines for the two groups are signi®cantly different over a broad range of micronutrient levels. This indicates a signi®cantly different dose ± response effect, where higher serum levels of both folate and vitamin B 12 are required to achieve the same homocysteine levels in the study group as in the control group. The plots of homocysteine vs folate and homocysteine vs vitamin B 12 show curvilinear relationships with log trend lines. These trend lines in the study group are signi®cantly to the right of that of the control group. Figure 3 shows the relationship between homocysteine and serum folate for the group of 43 with paired preoperative and 1 y results. The right shift in the dose ± response relationship is evident and there is a signi®-cant rise in homocysteine at 12 months when controlled for serum folate and vitamin B 12 levels (r 0.37, P`0.001). A signi®cant rise in homocysteine level is seen at 1 y despite a signi®cant rise in serum folate level (Table 3) .
Levels above the laboratory reference range upper level of 15 mmolal occurred in 14% of the study group and 4% of controls (P`0.001, chi-squared test). The American Heart Association (AHA) 14 recommended levels for patients at vascular risk of b10 mmolal were exceeded by 49% of the study group and 31% of the control group (P`0.001, chi-squared test).
Weight loss: folate and vitamin B 12 have greater in¯uence on homocysteine levels Correlation coef®cients were used to assess the in¯uence that serum folate and vitamin B 12 levels have on homocysteine levels. These are shown in Table 4 . Correlation coef®-cients for both serum folate and vitamin B 12 are higher, showing that they have greater in¯uence on homocysteine levels in the study group. Levels of folate and B 12 together explained only 9% (r 2 ) of the variance in homocysteine level in the control group but 35% (r 2 ) in the postoperative group P`0.001 (Table 4 ). In both groups serum folate levels correlated better with homocysteine levels than did RBC folate Weight loss and elevated homocysteine JB Dixon et al and, after controlling for serum folate, RBC folate levels had no signi®cant additional effect on homocysteine levels (not shown).
Vitamin B 12 and folate levels have signi®cant independent effects Serum folate and vitamin B 12 levels had signi®cant independent effects on homocysteine levels in both the study and control groups. Serum vitamin B 12 levels had a greater in¯uence on homocysteine levels in the study group, accounting for 9% (r À0.30, r 2 0.09, P`0.001) of the variance compared with 2% (r À0.14, r 2 0.02, P`0.05) in the control group, after controlling for the in¯uence of serum folate. Similarly after controlling for serum vitamin B 12 , serum folate levels accounted for 20% (r À0.45, r 2 0.2, P`0.001) of the variance of homocysteine level in the study group compared with 5% (r À0.23, r 2 0.05, P`0.01) in the control group. Thus the in¯uence both these micronutrients have on homocysteine levels is increased substantially and independently in the weight loss group.
Multivitamin supplements
Preoperatively 7% of the combined control and study group took regular multivitamins and a further 7% took them intermittently. At review 59% took multivitamins regularly, 18% intermittently and 23% never took them. The recommended supplement was used by 63% of the regular supplement takers and some took additional supplements; most of the others took equivalent multivitamin preparations.
Those in the study group who took regular multivitamin supplements were compared with those not taking any. Results show a signi®cant higher homocysteine level in those not taking supplements compared with regular supplement takers (Table 5 ). Levels of vitamin B 12 , serum folate and red-cell folate were all signi®cantly higher in the multivitamin takers (Table 5) . Patients who took supplements irregularly had serum folate, vitamin B 12 and homocysteine levels not statistically different from those not taking any at all (not shown).
The geometric mean homocysteine level of the group that took regular supplements was not signi®cantly different from the control group, but they did have signi®cantly higher levels of serum folate (P`0.001) and vitamin B 12 (P`0.01), shown in Table 5 . After controlling for both serum folate and vitamin B 12 levels, those taking multivitamin supplements had signi®cantly higher homocysteine levels (r 0.18, P`0.005) than those in the control group.
The signi®cance of the alteration in dose ± response relationships and importance of multivitamin supplementation is best illustrated when looking at the 67 not taking multivitamin supplements at 1 and 2 y follow up. Twenty-seven percent had homocysteine levels in excess of the reference range ( b15 mmolal) and 66% in excess of that recommended by the AHA for at risk groups ( b10 mmolal). These compare with 4% (P`0.001) and 31% (P`0.001), respectively, in the Figure 1 ln homocysteine levels vs ln serum folate levels for control (pre-operative obese patients) and study (weight loss) groups.
Weight loss and elevated homocysteine JB Dixon et al control group. While levels of homocysteine were clearly signi®cantly raised there were no signi®cant differences in levels of serum folate, RBC folate and vitamin B 12 between these groups (Table 5, P-values not shown in table) . There is a negative curvilinear relationship between homocysteine levels and levels of folate to at least 15 ngaml and vitamin B 12 to at least 600 pgaml (not shown). At levels above these, homocysteine levels plateau in the normal range. There were 24 subjects with this combination of folate greater than 15 ngaml and vitamin B 12 greater than 600 pgaml. All took multivitamins regularly at levels above the currently recommended minimum. All had homocysteine levels of 10 mmolal or below (mean 7.5 mmolal) and 20 of 24 were in the postoperative study group. The 20 in the postoperative group had a percentage excess weight loss of 47% which was no different from the whole group.
There was only a weak correlation between the extent of weight lost and homocysteine level (r 0.18, P`0.05) at 1 y, and no correlation at 2 y. All patients had a weight loss of greater than 7 kg at 1 y and 10 kg at 2 y. It is relevant that for the ®rst 2 y most patients are still in a phase of progressive weight loss.
Discussion
Our study has found a signi®cantly higher homocysteine level with weight loss after gastric restrictive surgery. The level may increase cardiovascular risk related to homocysteine and possibly the risk of neural tube defects. This effect occurs in the group as a whole and is more marked in those patients not taking multivitamin supplements. The bene®ts of regular multivitamin supplementation on homocysteine levels are clearly evident in this study.
There are three new and related ®ndings in this study:
(1) This study demonstrates an altered dose ± response relationship for both serum folate and vitamin B 12 with homocysteine levels in a group of patients losing weight after Lap-Band surgery. This alteration occurs over a wide range of folate and vitamin B 12 levels with higher serum levels of folate and vitamin B 12 required to maintain the same homocysteine level in those losing weight. (2) The in¯uence of both serum folate and vitamin B 12 on homocysteine levels is greatly increased in the weight loss group. (3) Vitamin B 12 levels have a signi®cant in¯uence on homocysteine levels in the group losing weight after controlling for serum folate. This may be relevant, as in the past much of the focus for lowering homocysteine levels has been on folate supplementation alone.
This indicates that metabolism controlled by the enzyme methionine synthetase is a likely site of this effect as it is the only human enzyme requiring both B 12 and folate. 15 There are a number of possible causes for an alteration in this important homocysteine re-methylation pathway:
An increased substrate load of methionine due to protein catabolism may occur during weight loss. On the other Weight loss and elevated homocysteine JB Dixon et al hand protein intake and therefore methionine intake is likely to be lower in association with negative energy balance in those subjects losing weight. Increased homocysteine levels may result from impaired catabolism of homocysteine via the trans-sulfuration pathway; the initial and rate-limiting step in this pathway is catalyzed by vitamin B 6 . A de®ciency of vitamin B 6 may therefore stress the folate-dependent methionine synthetase pathway and thereby an alteration in the relationship between folate, vitamin B 12 and homocysteine. It should be noted that the majority of our patients were also taking vitamin B 6 supplements. Weight loss and elevated homocysteine JB Dixon et al
Methylation of homocysteine via the alternative betaine pathway may be affected, leading to added load on the folate dependent methionine synthetase pathway.
There is a possibility that de®ciency of other micronutrients, minerals or trace elements affecting enzyme function may alter rate-limiting enzymes involved in homocysteine metabolism. It should be noted that higher levels of both folate and vitamin B 12 were required to maintain homocysteine levels in those taking multivitamins. The multivitamin supplement taken included vitamin B 6 , ribo¯avin, calcium and zinc, all known to have effects on some enzyme functions.
There are many metabolic effects of fasting and weight loss. Some are permanent and others acute phase effects. One of these may cause an acquired change in methionine synthetase or methyelenetetrahydrofolate reductase, leading to higher requirements of both vitamin B 12 and folate.
The accepted explanation for raised homocysteine levels in the fasting state has been folate or vitamin B 12 de®-ciency 16 and this is clearly not the case in this study. The cause of the effect we have described clearly needs further investigation.
There are important clinical implications of our ®nding and these are quite easy to implement. With higher serum levels of folate and vitamin B 12 needed to maintain homocysteine levels it is likely therefore that daily requirements of both folic acid and vitamin B 12 are increased during periods of weight loss in order to maintain advised homocysteine levels. Indeed our study shows that patients taking regular multivitamin supplements have higher serum levels of both folate and vitamin B 12 and lower levels of homocysteine than those not taking supplements. It has been shown that, at serum levels of folate above 15 ngaml, homocysteine levels are on a low normal plateau. 17 Our ®ndings con®rm this and in addition show a similar normal plateau for vitamin B 12 above 600 pgaml. Minimal homocysteine levels probably require both folate and vitamin B 12 at or above these levels.
Weight reduction after bariatric surgery is associated with dramatic improvements of known cardiovascular risk factors: type 2 diabetes, hypertension, dyslipidemia and obesity itself. This is likely to lead to a marked reduction in cardiovascular morbidity and mortality. It is, however, important to consider any potential increases in cardiovascular risks associated with weight loss and manage these appropriately. Many studies have shown that an elevated homocysteine is related to a broad range of vascular and thrombotic disease. It is associated with increased risk of myocardial infarction and death due to coronary artery disease. 18 An elevated homocysteine is an indicator of poor prognosis following myocardial infarction. 19 It is also associated with an increased risk of carotid artery disease and venous thromboembolism. 20 ± 22 There is evidence that homocysteine exerts a concentration-dependent vascular effect by promoting endothelial dysfunction and oxidative damage, an early event in the atherogenic process.
7,23 ± 25 A high intake of folate reduces homocysteine levels 26 and the risk of ischaemic heart disease. 27 Weight loss is often appropriately advised after major vascular events, although elevated homocysteine levels at this time may add risk. There is some evidence that weight loss has been associated with increased cardiovascular mortality. 28 The ®ndings in our study would suggest that multivitamin supplementation containing both folate and vitamin B 12 may be advisable in patients actively attempting to lose weight after major vascular events. We must await the results of long-term prospective controlled trials to truly assess the importance of homocysteine as a cardiovascular risk factor.
It is established that folic acid supplements can prevent neural tube defects. 29 Mills et al 15, 30 have shown increased homocysteine levels in women carrying a foetus with a neural tube defect. They hypothesize that the folate-and vitamin B 12 -dependent enzyme methionine synthetase is likely to be the critical pathway, with adequate methionine needed for neural tube closure. Cuskelly 31 showed that increasing dietary folic acid in food was inadequate and folate supplementation of 400 mgaday is recommended for women who could become pregnant to prevent neural tube defects. 29, 32 We advise all women with a Lap-Band who may possibly become pregnant to take folate 400 mg per day in addition to their normal multivitamin supplement. It is our policy to loosen the band by removing all the¯uid from it as early as possible in pregnancy, to allow optimal nutrition and a healthy weight gain during the pregnancy.
A folate supplement of 400 mg per day will minimize homocysteine levels in most people 33 and this is the minimum recommended dose for our at-risk group. In addition an oral supplement of vitamin B 12 is advisable and nutritional follow-up important after all forms of weight loss surgery. 24 recently published data on preeclampsia, showing raised levels of homocysteine and a clear association with cellular ®bronectin, a marker of endothelial damage. A plot of homocysteine with serum folate levels published in their manuscript has similarities to ours and may indicate that preeclampsia is another condition where there is an altered dose ± response relationship of homocysteine level with changes in serum folate and possibly vitamin B 12 levels. Could an altered dose ± response relationship also be acquired? This hypothesis clearly needs thorough investigation but the possibility that folate or multivitamin supplements taken throughout pregnancy may in¯uence the prevalence or severity of preeclampsia is attractive. Elevated homocysteine levels have been associated recently with a number of maternal and foetal complications including preeclampsia, prematurity, low-birth weight, stillbirth and developmental abnormalities such as neural tube defects and clubfoot. 34 The reported high prevalence of low folate and vitamin B 12 levels after malabsorbtive procedures and gastric bypass to achieve weight loss suggest raised homocysteine levels are likely.
1 ± 4 We have not found any reports of homocysteine levels measured following this type of surgery. It is likely that patients would suffer a combined effect of nutritional de®-ciency at a time of greater folate and vitamin B 12 requirements. A recent survey of lab tests ordered by bariatric surgeons performing surgery with a malabsorbtive component did not include homocysteine in the list. 35 This suggests it is rarely if ever ordered. We would urge measurement of homocysteine in these patients.
The adjustable gastric band allows for controlled weight loss with signi®cant weight loss still occurring in the second and third years after placement. 13 The ®nding of high homocysteine levels at the end of the second year when the rate of weight loss is usually low is important. This con®rms the need for continued nutritional monitoring and supplementation even when the rate of weight loss falls with time. We do not know when it would be appropriate to stop supplementation.
The ®nding of raised homocysteine levels in our patients has raised our awareness of the importance of appropriate nutritional advice and supplements. We would advocate the inclusion of homocysteine levels following bariatric surgery as part of the nutritional assessment. We use the homocysteine levels clinically as one important element in a nutritional feedback loop. Homocysteine levels help us reassure patients who are taking their supplements regularly. Levels often show good evidence that those not taking them need them, and ®nally they help us adjust supplements to individual requirements. Recently, patient compliance with supplementation has improved and the mean homocysteine level in our patients after surgery is falling.
Conclusion
We have found higher homocysteine levels in patients actively losing weight after Lap-Band surgery for morbid obesity in the absence of lower folate or vitamin B 12 levels. There is a signi®cant change in the relationship between serum levels of both folate and vitamin B 12 , and fasting homocysteine levels. This change has two related components: (a) an altered or shifted dose ± response relationship; and (b) folate and vitamin B 12 levels explaining signi®cantly greater variance in homocysteine levels in the weight loss group. These ®ndings are new and indicate that higher requirements of both these micronutrients are likely during periods of weight loss. The cause of this effect needs further investigation to determine its exact nature. While sustained weight loss has very favorable effects, a high homocysteine level may be suf®cient to increase cardiovascular risk, and may put mothers-to-be at increased risk of neural tube abnormalities in their children. These ®ndings may have important implications for other groups losing weight or other conditions where an altered dose ± response relationship may exist.
